8G2M

The tumor activated anti-CTLA-4 monoclonal antibody XTX101 demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer

External Resource: Annotation

SAbDab Antibody Annotation
Thera-SAbDab Antibody Annotation

SAbDab Antibody Annotation SAbDab Database Homepage

Chain	Chain Class	Chain Subclass	Chain Type	Antigen Name(s)	Provenance Source
C [auth L]	Light Chain	IGKV6	Kappa	masking peptide	SAbDab (2024-06-07)
B [auth H]	Heavy Chain	IGHV1	-	masking peptide	SAbDab (2024-06-07)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

Chain	Name	Target	Provenance Source
C [auth L]	Vilastobart	CTLA4/CD152	Therapeutic SAbDab (2024-06-07)
B [auth H]	Vilastobart	CTLA4/CD152	Therapeutic SAbDab (2024-06-07)

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.